These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 25458420)

  • 1. Study of the virulence of serotypes 4 and 9 of African horse sickness virus in IFNAR(-/-), Balb/C and 129 Sv/Ev mice.
    de la Grandière MA; Dal Pozzo F; Tignon M; Zonta W; Thiry D; Mauroy A; Mathijs É; Caij AB; Saegerman C; Thiry É
    Vet Microbiol; 2014 Dec; 174(3-4):322-332. PubMed ID: 25458420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assembly of Replication-Incompetent African Horse Sickness Virus Particles: Rational Design of Vaccines for All Serotypes.
    Lulla V; Lulla A; Wernike K; Aebischer A; Beer M; Roy P
    J Virol; 2016 Aug; 90(16):7405-7414. PubMed ID: 27279609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a mouse model system, coding assignments and identification of the genome segments controlling virulence of African horse sickness virus serotypes 3 and 8.
    O'Hara RS; Meyer AJ; Burroughs JN; Pullen L; Martin LA; Mertens PP
    Arch Virol Suppl; 1998; 14():259-79. PubMed ID: 9785512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. African horse sickness virus (AHSV) with a deletion of 77 amino acids in NS3/NS3a protein is not virulent and a safe promising AHS Disabled Infectious Single Animal (DISA) vaccine platform.
    van Rijn PA; Maris-Veldhuis MA; Potgieter CA; van Gennip RGP
    Vaccine; 2018 Apr; 36(15):1925-1933. PubMed ID: 29525278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural Protein VP2 of African Horse Sickness Virus Is Not Essential for Virus Replication In Vitro.
    van Gennip RGP; van de Water SGP; Potgieter CA; van Rijn PA
    J Virol; 2017 Feb; 91(4):. PubMed ID: 27903804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ns1 is a key protein in the vaccine composition to protect Ifnar(-/-) mice against infection with multiple serotypes of African horse sickness virus.
    de la Poza F; Calvo-Pinilla E; López-Gil E; Marín-López A; Mateos F; Castillo-Olivares J; Lorenzo G; Ortego J
    PLoS One; 2013; 8(7):e70197. PubMed ID: 23894615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. VP2 Exchange and NS3/NS3a Deletion in African Horse Sickness Virus (AHSV) in Development of Disabled Infectious Single Animal Vaccine Candidates for AHSV.
    van de Water SG; van Gennip RG; Potgieter CA; Wright IM; van Rijn PA
    J Virol; 2015 Sep; 89(17):8764-72. PubMed ID: 26063433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cross-protective immune responses against African horse sickness virus after vaccination with protein NS1 delivered by avian reovirus muNS microspheres and modified vaccinia virus Ankara.
    Marín-López A; Barreiro-Piñeiro N; Utrilla-Trigo S; Barriales D; Benavente J; Nogales A; Martínez-Costas J; Ortego J; Calvo-Pinilla E
    Vaccine; 2020 Jan; 38(4):882-889. PubMed ID: 31708178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytokine mRNA Expression Profile in Target Organs of IFNAR (-/-) Mice Infected with African Horse Sickness Virus.
    Calvo-Pinilla E; Jiménez-Cabello L; Utrilla-Trigo S; Illescas-Amo M; Ortego J
    Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiserum from mice vaccinated with modified vaccinia Ankara virus expressing African horse sickness virus (AHSV) VP2 provides protection when it is administered 48h before, or 48h after challenge.
    Calvo-Pinilla E; de la Poza F; Gubbins S; Mertens PP; Ortego J; Castillo-Olivares J
    Antiviral Res; 2015 Apr; 116():27-33. PubMed ID: 25643968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative Genome Analysis of All Nine African Horse Sickness Serotypes Isolated From Equine Fatalities in Kenya and South Africa.
    Hoffmann B; Joseph S; Patteril NAG; Caveney MR; Elizabeth SK; Muhammed R; Wernery R; Wernery U
    J Equine Vet Sci; 2022 Dec; 119():104137. PubMed ID: 36223818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Requirements and comparative analysis of reverse genetics for bluetongue virus (BTV) and African horse sickness virus (AHSV).
    van Rijn PA; van de Water SG; Feenstra F; van Gennip RG
    Virol J; 2016 Jul; 13():119. PubMed ID: 27368544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccination with recombinant Modified Vaccinia Ankara (MVA) viruses expressing single African horse sickness virus VP2 antigens induced cross-reactive virus neutralising antibodies (VNAb) in horses when administered in combination.
    Manning NM; Bachanek-Bankowska K; Mertens PPC; Castillo-Olivares J
    Vaccine; 2017 Oct; 35(44):6024-6029. PubMed ID: 28438410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective efficacy of multivalent replication-abortive vaccine strains in horses against African horse sickness virus challenge.
    Lulla V; Losada A; Lecollinet S; Kerviel A; Lilin T; Sailleau C; Beck C; Zientara S; Roy P
    Vaccine; 2017 Jul; 35(33):4262-4269. PubMed ID: 28625521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A single dose of African horse sickness virus (AHSV) VP2 based vaccines provides complete clinical protection in a mouse model.
    Aksular M; Calvo-Pinilla E; Marín-López A; Ortego J; Chambers AC; King LA; Castillo-Olivares J
    Vaccine; 2018 Nov; 36(46):7003-7010. PubMed ID: 30309744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccination of mice with a modified Vaccinia Ankara (MVA) virus expressing the African horse sickness virus (AHSV) capsid protein VP2 induces virus neutralising antibodies that confer protection against AHSV upon passive immunisation.
    Calvo-Pinilla E; de la Poza F; Gubbins S; Mertens PP; Ortego J; Castillo-Olivares J
    Virus Res; 2014 Feb; 180():23-30. PubMed ID: 24333835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterising Non-Structural Protein NS4 of African Horse Sickness Virus.
    Zwart L; Potgieter CA; Clift SJ; van Staden V
    PLoS One; 2015; 10(4):e0124281. PubMed ID: 25915516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. African horse sickness outbreaks caused by multiple virus types in Ethiopia.
    Aklilu N; Batten C; Gelaye E; Jenberie S; Ayelet G; Wilson A; Belay A; Asfaw Y; Oura C; Maan S; Bachanek-Bankowska K; Mertens PP
    Transbound Emerg Dis; 2014 Apr; 61(2):185-92. PubMed ID: 23083078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serological and virological responses in mules and donkeys following inoculation with African horse sickness virus serotype 4.
    el Hasnaoui H; el Harrak M; Zientara S; Laviada M; Hamblin C
    Arch Virol Suppl; 1998; 14():29-36. PubMed ID: 9785493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A modified vaccinia Ankara virus (MVA) vaccine expressing African horse sickness virus (AHSV) VP2 protects against AHSV challenge in an IFNAR -/- mouse model.
    Castillo-Olivares J; Calvo-Pinilla E; Casanova I; Bachanek-Bankowska K; Chiam R; Maan S; Nieto JM; Ortego J; Mertens PP
    PLoS One; 2011 Jan; 6(1):e16503. PubMed ID: 21298069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.